TSCAN THERAPEUTICS INC. - COMMON STOCK

TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures

12 Sep 2022 04:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

07 Sep 2022 04:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress

10 Aug 2022 04:00:00 By Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference

03 Aug 2022 04:00:02 By Nasdaq GlobeNewswire

TScan Therapeutics Announces Publication in Cell Highlighting the Discovery of Tumor Antigens and TCRs for the Treatment of Solid Tumors Using Foundational Screening Technology

11 Jul 2022 04:00:00 By Nasdaq GlobeNewswire

TScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer

07 Jul 2022 04:00:00 By Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium

22 Jun 2022 04:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the 2022 Jefferies Healthcare Conference

02 Jun 2022 04:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-101 for the Treatment of Hematologic Malignancies

31 May 2022 04:00:00 By Nasdaq GlobeNewswire

TScan Therapeutics Presents Preclinical Data at the American Society of Gene and Cell Therapy 25th Annual Meeting

19 May 2022 04:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

17 May 2022 04:00:02 By Nasdaq GlobeNewswire

TScan Therapeutics to Host Virtual KOL Event to Discuss its Solid Tumor Program Strategy and Highlights from the ASGCT 25th Annual Meeting

12 May 2022 04:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones

09 May 2022 04:00:02 By Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Presentations at the 25th American Society of Gene and Cell Therapy Annual Meeting

02 May 2022 14:02:38 By Nasdaq GlobeNewswire

TScan Therapeutics Appoints Leiden Dworak, CPA, MBA, as Vice President, Finance

11 Apr 2022 04:00:00 By Nasdaq GlobeNewswire

TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities

09 Mar 2022 04:00:00 By Nasdaq GlobeNewswire

TScan Therapeutics to Participate in Upcoming Investor Conferences

02 Mar 2022 04:00:00 By Nasdaq GlobeNewswire

TScan Therapeutics Announces Presentation at the 11th Annual SVB Leerink Global Healthcare Conference

10 Feb 2022 04:00:02 By Nasdaq GlobeNewswire

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-100 for the Treatment of Hematologic Malignancies

24 Jan 2022 04:00:01 By Nasdaq GlobeNewswire

TScan Outlines 2022 Priorities as Programs Enter Clinic

10 Jan 2022 04:00:03 By Nasdaq GlobeNewswire